CK Hutchison trims Chi-Med stake through placement
CK Hutchison Holdings is paring down its stake in Hutchison China MediTech (Chi-Med) through a placement after the biopharmaceutical company put its planned Hong Kong IPO on the back burner.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: